

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001816"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001816" />

    <meta name="citation_title" content="Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors"/>
    <meta itemprop="name" content="Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors"/>

      <meta name="citation_author" content="Chad J. Creighton"/>
            <meta name="citation_author_institution" content="Division of Biostatistics, Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America"/>

    <meta name="citation_date" content="2008/3/19"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001816.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1816"/>
    <meta name="citation_issue" content="3"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=The hallmarks of cancer.; citation_author=D Hanahan; citation_author=RA Weinberg; citation_journal_title=Cell; citation_volume=100; citation_number=1; citation_pages=57-70; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer.; citation_author=J Lamb; citation_author=S Ramaswamy; citation_author=HL Ford; citation_author=B Contreras; citation_author=RV Martinez; citation_journal_title=Cell; citation_volume=114; citation_number=2; citation_pages=323-334; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Oncogenic pathway signatures in human cancers as a guide to targeted therapies.; citation_author=AH Bild; citation_author=G Yao; citation_author=JT Chang; citation_author=Q Wang; citation_author=A Potti; citation_journal_title=Nature; citation_volume=439; citation_number=3; citation_pages=353-7; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.; citation_author=CJ Creighton; citation_author=AM Hilger; citation_author=S Murthy; citation_author=JM Rae; citation_author=AM Chinnaiyan; citation_journal_title=Cancer Res; citation_volume=66; citation_number=4; citation_pages=3903-11; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Gene expression profiling predicts clinical outcome of prostate cancer.; citation_author=GV Glinsky; citation_author=AB Glinskii; citation_author=AJ Stephenson; citation_author=RM Hoffman; citation_author=WL Gerald; citation_journal_title=J Clin Invest; citation_volume=113; citation_number=5; citation_pages=913-23; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.; citation_author=YP Yu; citation_author=D Landsittel; citation_author=L Jing; citation_author=J Nelson; citation_author=B Ren; citation_journal_title=J Clin Oncol; citation_volume=22; citation_number=6; citation_pages=2790-9; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Gene expression profiling identifies clinically relevant subtypes of prostate cancer.; citation_author=J Lapointe; citation_author=C Li; citation_author=JP Higgins; citation_author=M van de Rijn; citation_author=E Bair; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=101; citation_number=7; citation_pages=811-6; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Gene expression correlates of clinical prostate cancer behavior.; citation_author=D Singh; citation_author=PG Febbo; citation_author=K Ross; citation_author=DG Jackson; citation_author=J Manola; citation_journal_title=Cancer Cell; citation_volume=1; citation_number=8; citation_pages=203-9; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.; citation_author=DR Rhodes; citation_author=TR Barrette; citation_author=MA Rubin; citation_author=D Ghosh; citation_author=AM Chinnaiyan; citation_journal_title=Cancer Res; citation_volume=62; citation_number=9; citation_pages=4427-4433; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Identification of genes periodically expressed in the human cell cycle and their expression in tumors.; citation_author=ML Whitfield; citation_author=G Sherlock; citation_author=AJ Saldanha; citation_author=JI Murray; citation_author=CA Ball; citation_journal_title=Mol Biol Cell; citation_volume=13; citation_number=10; citation_pages=1977-2000; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Transcriptional programs activated by exposure of human prostate cancer cells to androgen.; citation_author=SE DePrimo; citation_author=M Diehn; citation_author=JB Nelson; citation_author=RE Reiter; citation_author=J Matese; citation_journal_title=Genome Biol; citation_volume=3; citation_number=11; citation_pages=R32; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Molecular determinants of resistance to antiandrogen therapy.; citation_author=CD Chen; citation_author=DS Welsbie; citation_author=C Tran; citation_author=SH Baek; citation_author=R Chen; citation_journal_title=Nat Med; citation_volume=10; citation_number=12; citation_pages=33-9; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.; citation_author=HA Coller; citation_author=C Grandori; citation_author=P Tamayo; citation_author=T Colbert; citation_author=ES Lander; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=97; citation_number=13; citation_pages=3260-5; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.; citation_author=PK Majumder; citation_author=PG Febbo; citation_author=R Bikoff; citation_author=R Berger; citation_author=Q Xue; citation_journal_title=Nat Med; citation_volume=10; citation_number=14; citation_pages=594-601; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.; citation_author=CJ Creighton; citation_author=KE Cordero; citation_author=JM Larios; citation_author=RS Miller; citation_author=MD Johnson; citation_journal_title=Genome Biol; citation_volume=7; citation_number=15; citation_pages=R28; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Discovering statistically significant pathways in expression profiling studies.; citation_author=L Tian; citation_author=SA Greenberg; citation_author=SW Kong; citation_author=J Altschuler; citation_author=IS Kohane; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=102; citation_number=16; citation_pages=13544-9; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Real-Time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies.; citation_author=U Lehmann; citation_author=H Kreipe; citation_journal_title=Methods; citation_volume=25; citation_number=17; citation_pages=409-418; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Molecular genetics of prostate cancer.; citation_author=C Abate-Shen; citation_author=MM Shen; citation_journal_title=Genes Dev; citation_volume=14; citation_number=18; citation_pages=2410-34; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Molecular pathology of prostate cancer.; citation_author=C Hughes; citation_author=A Murphy; citation_author=C Martin; citation_author=O Sheils; citation_author=J O'Leary; citation_journal_title=J Clin Pathol; citation_volume=58; citation_number=19; citation_pages=673-84; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=SRC gene expression in human cancer: the role of transcriptional activation.; citation_author=SM Dehm; citation_author=K Bonham; citation_journal_title=Biochem Cell Biol; citation_volume=82; citation_number=20; citation_pages=263-74; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer.; citation_author=MP Paronetto; citation_author=D Farini; citation_author=I Sammarco; citation_author=G Maturo; citation_author=G Vespasiani; citation_journal_title=Am J Pathol; citation_volume=164; citation_number=21; citation_pages=1243-51; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Myc-driven murine prostate cancer shares molecular features with human prostate tumors.; citation_author=K Ellwood-Yen; citation_author=TG Graeber; citation_author=J Wongvipat; citation_author=ML Iruela-Arispe; citation_author=J Zhang; citation_journal_title=Cancer Cell; citation_volume=4; citation_number=22; citation_pages=223-38; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.; citation_author=A Sweet-Cordero; citation_author=S Mukherjee; citation_author=A Subramanian; citation_author=H You; citation_author=JJ Roix; citation_journal_title=Nat Genet; citation_volume=37; citation_number=23; citation_pages=48-55; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.; citation_author=KK Deeb; citation_author=AM Michalowska; citation_author=CY Yoon; citation_author=SM Krummey; citation_author=MJ Hoenerhoff; citation_journal_title=Cancer Res; citation_volume=2007 Sep 1;67(17); citation_number=24; citation_pages=8065-80; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Cluster analysis and display of genome-wide expression patterns.; citation_author=MB Eisen; citation_author=PT Spellman; citation_author=PO Brown; citation_author=D Botstein; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=95; citation_number=25; citation_pages=14863-8; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Java Treeview–extensible visualization of microarray data.; citation_author=AJ Saldanha; citation_journal_title=Bioinformatics; citation_volume=20; citation_number=26; citation_pages=3246-8; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Statistical significance for genomewide studies.; citation_author=JD Storey; citation_author=R Tibshirani; citation_journal_title=Proc Natl Acad Sci U S A; citation_volume=100; citation_number=27; citation_pages=9440-9445; citation_date=2003; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors"/>
    <meta name="twitter:description" content="BackgroundGene transcription patterns associated with activation of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, as well as of the cell cycle and of androgen signaling have been generated in previous studies using experimental models. It was not clear whether genes in these &ldquo;oncogenic signatures&rdquo; would show coordinate expression patterns in human prostate tumors, particularly as most of the signatures were derived from cell types other than prostate.Principal FindingsThe above oncogenic pathway signatures were examined in four different gene expression profile datasets of human prostate tumors (representing &sim;250 patients in all), using both Q1-Q2 and one-sided Fisher's exact enrichment analysis methods. A significant fraction (&sim;5%) of genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen were co-expressed in human tumors with the oncogene or biomarker corresponding to the pathway signature. Genes down-regulated experimentally, however, did not show anticipated patterns of anti-enrichment in the human tumors.ConclusionsSignificant subsets of the genes in these experimentally-derived oncogenic signatures are relevant to the study of human prostate cancer. Both molecular biologists and clinical researchers could focus attention on the relatively small number of genes identified here as having coordinate patterns that arise from both the experimental system and the human disease system."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001816.g002"/>

  <meta property="og:title" content="Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=4913'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=2226'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=9383&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001816">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001816" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001816&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Chad J. Creighton
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">* E-mail:</span> <a href="mailto:creighto@bcm.edu">creighto@bcm.edu</a></p>

                <p>Affiliation:
                  Division of Biostatistics, Department of Medicine, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: March 19, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001816</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001816-g001" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001816-t001" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001816-t002" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t002" title="Table 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001816-g002" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001816-t003" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t003" title="Table 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001816">Reader Comments (1)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001816" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2>
<h3>Background</h3>
<a id="article1.front1.article-meta1.abstract1.sec1.p1" name="article1.front1.article-meta1.abstract1.sec1.p1"></a><p>Gene transcription patterns associated with activation of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, as well as of the cell cycle and of androgen signaling have been generated in previous studies using experimental models. It was not clear whether genes in these “oncogenic signatures” would show coordinate expression patterns in human prostate tumors, particularly as most of the signatures were derived from cell types other than prostate.</p>


<h3>Principal Findings</h3>
<a id="article1.front1.article-meta1.abstract1.sec2.p1" name="article1.front1.article-meta1.abstract1.sec2.p1"></a><p>The above oncogenic pathway signatures were examined in four different gene expression profile datasets of human prostate tumors (representing ~250 patients in all), using both Q1-Q2 and one-sided Fisher's exact enrichment analysis methods. A significant fraction (~5%) of genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen were co-expressed in human tumors with the oncogene or biomarker corresponding to the pathway signature. Genes down-regulated experimentally, however, did not show anticipated patterns of anti-enrichment in the human tumors.</p>


<h3>Conclusions</h3>
<a id="article1.front1.article-meta1.abstract1.sec3.p1" name="article1.front1.article-meta1.abstract1.sec3.p1"></a><p>Significant subsets of the genes in these experimentally-derived oncogenic signatures are relevant to the study of human prostate cancer. Both molecular biologists and clinical researchers could focus attention on the relatively small number of genes identified here as having coordinate patterns that arise from both the experimental system and the human disease system.</p>

</div>


<div class="articleinfo"><p><strong>Citation: </strong>Creighton CJ (2008) Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors. PLoS ONE 3(3):
          e1816.
            doi:10.1371/journal.pone.0001816</p><p><strong>Academic Editor: </strong>Jörg Hoheisel, Deutsches Krebsforschungszentrum, Germany</p><p><strong>Received:</strong> December 11, 2007; <strong>Accepted:</strong> February 20, 2008; <strong>Published:</strong> March 19, 2008</p><p><strong>Copyright:</strong> © 2008 Chad Creighton. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>CJC was supported in part by NIH grant P30 CA125123, and the Dan L. Duncan Cancer Center at Baylor College of Medicine. No funding source played any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.</p><p><strong>Competing interests:</strong> The author has declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Cancer is a disease characterized by DNA damage and widespread deregulation of cell signaling and gene transcription. Genes with roles in cancer can be broadly grouped into oncogenes, tumor supressors, and DNA damage-associated genes. Oncogenes promote cancer by over-expression or hyper-activation. The molecular pathways leading to oncogenesis and tumor progression are diverse <a href="#pone.0001816-Hanahan1">[1]</a>. Much progress has been made in the past 30 years in defining these pathways at the level of signal transduction involving protein-to-protein interaction. However, signal transduction leads through the chain of events to transcriptional regulation of a specific set of genes <a href="#pone.0001816-Hanahan1">[1]</a>. With the advent of global gene expression profiling technology within the last ten years, we can now more readily examine oncogenic pathways at the level of gene transcription. Through the use of experimental models such as cell cultures or transgenic mice, one may turn up the expression or activity of a specific gene and observe which genes are regulated as a result.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Here an oncogenic pathway signature will be defined to mean a set of genes that show a specific pattern of up- or down-regulation when a given pathway associated with oncogenesis is activated. Oncogenic signatures observed experimentally have potential use for inferring pathway deregulation in human tumors. In a seminal study by Lamb <em>et al</em>. <a href="#pone.0001816-Lamb1">[2]</a>, a set of genes induced by cyclin D1 in an <em>in vitro</em> model were found to be co-expressed as a group with cyclin D1 mRNA in multiple expression profile datasets of human tumors of various types. In a recent study by Bild <em>et al</em>. <a href="#pone.0001816-Bild1">[3]</a>, gene signatures of Myc, Ras, E2F3, Src, and beta-catenin defined <em>in vitro</em> were used to predict Ras mutation status in human lung tumors and to predict the response of a panel of breast cancer cell lines to Src or Ras inhibitors. In another study by Creighton <em>et al</em>. <a href="#pone.0001816-Creighton1">[4]</a>, a signature of the MAP kinase pathway was defined from gene expression profiles of ErbB-2 (HER2), EGFR, Raf, and MEK in MCF-7 cells; this MAPK signature was found to share extensive similarities with signatures of ER-negative human breast cancer, which commonly has hyper-activated MAPK.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>The oncogenic pathway signatures described above were generated from gene expression profiling of breast cell cultures. One question addressed here was which signatures could be considered relevant to human cancers of a different cell type from breast, in other words, whether genes associated with a given pathway in an experimental model show patterns of expression in human tumors that would be consistent with that pathway association. In the case of the Lamb cyclin D1 signature, human tumors of various cell types (including breast and prostate) that had high levels of cyclin D1 were found to express high levels of genes in the cyclin D1 signature <a href="#pone.0001816-Lamb1">[2]</a>. This present study explored whether oncogenic signatures from other studies followed similar patterns in human prostate cancer. The focus of this study was in prostate cancer, as it is the most commonly occurring cancer in males in the United States, and as there were several profile datasets of human prostate cancer that were publically available.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>Here, mRNA signatures of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, along with signatures of the cell cycle and of androgen signaling, were collected from eight previously published studies. As there have been multiple profiling studies of human prostate tumors <a href="#pone.0001816-Glinsky1">[5]</a>–<a href="#pone.0001816-Singh1">[8]</a>, one can look for gene expression patterns that are common across independent datasets <a href="#pone.0001816-Rhodes1">[9]</a>. These oncogenic signatures were therefore examined in four different profile datasets of prostate tumors. As mentioned above, the aim of this study was to determine if these experimentally-defined oncogenic pathway signatures were relevant to human prostate cancer. The specific hypothesis tested was that human prostate tumors with (relatively) high mRNA levels of a given oncogene should also show high levels of the group of genes found over-expressed in the experimental setting when the same oncogene is turned up. One important outcome of this analysis was a catalog of the genes from a given experimentally-derived pathway signature that also had expression patterns considered relevant to the human tumors, which provides a resource for future functional studies.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results"></a><h3>Results</h3>
<h4>A collection of gene transcription signatures of oncogenic pathways from various studies</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Using gene expression profile datasets of cell culture and mouse models from previously published studies (listed in <a href="#pone-0001816-t001">Table 1</a>), gene signatures of 14 different oncogenic pathways were defined. These signatures are described in <a href="#pone-0001816-t002">Table 2</a> and shown graphically in <a href="#pone-0001816-g001">Figure 1</a>. The pathways represented by these signatures were the following: (1) Myc, c-Src, beta-catenin, E2F3, and H-Ras, from the study by Bild <em>et al</em>. <a href="#pone.0001816-Bild1">[3]</a>; (2) erbB-2 (HER2), EGFR, MEK, Raf, and MAPK from Creighton <em>et al</em>. <a href="#pone.0001816-Creighton1">[4]</a>; (3) the cell cycle from Whitfield <em>et al</em>. <a href="#pone.0001816-Whitfield1">[10]</a>; (4) androgen receptor (AR) signaling, from Deprimo <em>et al</em>. <a href="#pone.0001816-DePrimo1">[11]</a>; (5) AR signaling, from Chen <em>et al</em>. <a href="#pone.0001816-Chen1">[12]</a>; (6) Myc, from Coller <em>et al</em>. <a href="#pone.0001816-Coller1">[13]</a>; (7) cyclin D1, from Lamb <em>et al</em>. <a href="#pone.0001816-Lamb1">[2]</a>; and (7) Akt, from Majumder <em>et al</em>. <a href="#pone.0001816-Majumder1">[14]</a>. The unique named genes involved in each of these signatures are listed in Supplementary <a href="#pone.0001816.s001">Data File S1</a>.</p>
<div class="figure" id="pone-0001816-g001"><div class="img"><a name="pone-0001816-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001816.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001816.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Gene expression patterns indicative of oncogenic pathway deregulation.</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>RNA profiling datasets were collected from various published studies (described in <a href="#pone-0001816-t002">Table 2</a>) in which a particular pathway was activated in an experimental model. Expression patterns are represented as a color map. Each row represents a gene; each column represents a sample. The level of expression of each gene in each sample is represented using a yellow–blue color scale (yellow: high expression). Pathways represented are the following: (A) Myc, c-Src, beta-catenin, E2F3, and H-Ras, from the study by Bild <em>et al</em>. <a href="#pone.0001816-Bild1">[3]</a>; (B) erbB-2 (HER2), EGFR, MEK, Raf, and MAPK from Creighton <em>et al</em>. <a href="#pone.0001816-Creighton1">[4]</a>; (C) the cell cycle from Whitfield <em>et al</em>. <a href="#pone.0001816-Whitfield1">[10]</a>; (D) androgen receptor (AR) signaling, from Deprimo <em>et al</em>. <a href="#pone.0001816-DePrimo1">[11]</a>; (E) AR signaling, from Chen <em>et al</em>. <a href="#pone.0001816-Chen1">[12]</a>; (F) Myc, from Coller <em>et al</em>. <a href="#pone.0001816-Coller1">[13]</a>; (G) cyclin D1, from Lamb <em>et al</em>. <a href="#pone.0001816-Lamb1">[2]</a>; (H) Akt, from Majumder <em>et al</em>. <a href="#pone.0001816-Majumder1">[14]</a>. (I) Graphical representation of the significance of gene overlap (by one-sided Fisher's exact test, using as the reference population the entire set of 14130 genes represented among any of the array platforms) between the various pathway signatures (focusing here on the sets of genes up-regulated in each signature).</p>
<span>doi:10.1371/journal.pone.0001816.g001</span></div><div class="figure" id="pone-0001816-t001"><div class="img"><a name="pone-0001816-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>Public gene expression profile datasets used in this study.</span></strong></p><span>doi:10.1371/journal.pone.0001816.t001</span></div><div class="figure" id="pone-0001816-t002"><div class="img"><a name="pone-0001816-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t002.TIF"></span>)
                </a></li></ul></div><p><strong>Table 2.  <span>Oncogenic pathway gene signatures surveyed in prostate cancer (PCA).</span></strong></p><span>doi:10.1371/journal.pone.0001816.t002</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>For each oncogenic signature, one set of genes were up-regulated and another set were down-regulated in response to activation of the associated pathway. Statistical criteria for defining each signature are given in the <a href="#s4">Methods</a> section. Where selecting genes from profile data is a balance between false negatives and false positives, the selection cutoffs is this study leaned towards having fewer false negatives and more gene information. The <em>p</em>-value cutoffs used to define each signature were, in a sense, arbitrarily chosen, the idea being that a “sizable” number of genes (on the order of a few to several hundred) were desired to represent each pathway. Because of the wide spectrum of experimental systems, conditions, laboratories, and array platforms represented among all of the profile datasets, it was not possible to analyze all of the datasets in the same way and to use a single <em>p</em>-value cut off (e.g. <em>p</em>&lt;0.01 for each comparison). There are many possible alternative methods and thresholds for defining the oncogenic signatures that might have been used and which could have been considered equally valid. The author believes that any reasonable analytic approach for defining signatures that yielded numbers of genes comparable to those in <a href="#pone-0001816-t002">Table 2</a> would have resulted in the same overall patterns of enrichment being observed between the signatures and the human tumors.</p>
<a id="article1.body1.sec2.sec1.p3" name="article1.body1.sec2.sec1.p3"></a><p>Different oncogenic pathways may regulate common genes. The oncogenic signatures in this study were compared with each other to see which pairs of signatures shared significant gene overlap. These signature-to-signature associations are shown graphically in <a href="#pone-0001816-g001">Figure 1I</a> (focusing only on the set of genes up-regulated in each signature). A significant overlap of 40 genes between the set up-regulated by Myc in the Bild dataset (993 unique named genes) and the set up-regulated in the Coller dataset (252 genes) was observed (expected 18 genes, one-sided Fisher's exact <em>p</em>&lt;1E-06, using as the reference population the entire set of 14130 genes represented among any of the array platforms), which shows good agreement between signatures of the same pathway generated independently by different labs using different experimental systems. Similarly, significant overlap was observed between the Deprimo and Chen sets of androgen-inducible genes (87 genes overlapping between 259 and 559 genes, respectively, one-sided Fisher's exact <em>p</em>&lt;1E-57).</p>
<a id="article1.body1.sec2.sec1.p4" name="article1.body1.sec2.sec1.p4"></a><p>Furthermore, significant overlap was observed between signatures representing different pathways. The overlap between the Creighton erbB-2, EGFR, Raf, and MEK signatures had been noted previously <a href="#pone.0001816-Creighton1">[4]</a>, and was defined as a common MAPK signature. The overlap between the Bild Ras signature and the Creighton MAPK-associated signatures makes sense, as Ras is also a key intermediate of the MAPK pathway. In addition, the signature genes for cell cycle regulator E2F3 in the Bild data overlapped significantly with the set of genes correlated with cell cycle progression in the Whitfield data. Other signature-to-signature associations appear novel and intriguing, such as an association between the Akt pathway and the MAPK-associated pathways (<a href="#pone-0001816-g001">Figure 1I</a>). It is important to note that different signatures may share common genes, yet show widespread differences at the same time. For example, the Creighton MAPK-associated signatures shared a common MAPK signature, yet each of these signatures also had a distinct expression pattern from the other signatures (<a href="#pone-0001816-g001">Figure 1B</a>). The complete lists of corresponding genes overlapping among the various signatures are provided as Supplementary <a href="#pone.0001816.s002">Data File S2</a>.</p>


<h4>Genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen are co-expressed in human prostate tumors with Myc, c-Src, HER2, Akt, or PSA, respectively</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>The oncogenic pathway signatures of <a href="#pone-0001816-t002">Table 2</a> and <a href="#pone-0001816-g001">Figure 1</a> were derived from a number of experimental models, several of these signatures being derived from breast cell cultures in particular. An important question was whether these signatures would be relevant to the study of human prostate cancer, or would simply represent tissue-specific or model-specific effects on gene expression. Previously, cyclin D1-regulated genes from the Lamb profile dataset and Myc-regulated genes from the Coller dataset were each shown to be coordinately expressed with <em>CCND1</em> and <em>MYC</em> mRNA expression, respectively, in various tumor datasets <a href="#pone.0001816-Lamb1">[2]</a>, <a href="#pone.0001816-Creighton2">[15]</a>. Here, the entire collection of oncogenic signatures from <a href="#pone-0001816-t002">Table 2</a> was examined in each of four different expression profile datasets of primary human prostate cancers (PCA) from previous studies <a href="#pone.0001816-Glinsky1">[5]</a>–<a href="#pone.0001816-Singh1">[8]</a> (listed in <a href="#pone-0001816-t001">Table 1</a>), representing 253 individual prostate cases in all (Glinsky <em>et al</em>. dataset: 79 tumors, Yu: 60, Lapointe: 62, Singh: 52). Seven individual genes represented in the human datasets were of particular interest: <em>KLK3</em> (which encodes prostate-specific antigen, or PSA), <em>MYC</em>, <em>SRC</em> (which encodes c-Src), <em>ERBB2</em>, <em>EGFR</em>, <em>CCND1</em>, and <em>AKT1</em>. Each of these genes is an oncogene commonly over-expressed in cancers, with the exception of <em>KLK3</em>, a well-known gene target of androgen signaling. The hypothesis tested below with each of these seven genes was that prostate tumors with high expression (relative to other tumors) of either an oncogene or a biomarker of an oncogenic pathway would also show high expression of a significant number of genes up-regulated experimentally in the corresponding pathway signature. Additionally, these tumors with relatively high oncogene levels might show under-expression of a significant number of genes down-regulated in the pathway signature.</p>
<a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>For each of the seven oncogenes mentioned above, the genes most correlated (i.e. similar) in expression to the given oncogene were determined in each of the four prostate datasets. Gene correlates of the oncogene were tested for enrichment of each of the 16 oncogenic pathway signature gene sets of <a href="#pone-0001816-t002">Table 2</a>. As each pathway signature had a set of genes up-regulated and another set down-regulated in response to pathway activation, the “up” genes were evaluated for enrichment separately from the “down” genes. The test of enrichment used here was the rigorous, rank-based “Q1-Q2” statistic of Tian <em>et al</em>. <a href="#pone.0001816-Tian1">[16]</a> (schematic in <a href="#pone-0001816-g002">Figure 2A</a>), which demonstrated significance of enrichment over what may be expected using a randomly-generated set of pathway signature genes (the “Q1” hypothesis) or using a random ordering of reference oncogene values in the human tumor dataset (the “Q2” hypothesis). Besides the seven oncogenes of interest, other genes, such as genes encoding MAPK or beta-catenin, were represented by pathway signatures, though many of these other genes are typically mutated or hyper-activated in cancer, rather than over-expressed.</p>
<div class="figure" id="pone-0001816-g002"><div class="img"><a name="pone-0001816-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001816.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001816.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Patterns of enrichment involving selected oncogenes (<em>KLK3</em> i.e. PSA, <em>MYC</em>, <em>SRC</em>, <em>ERBB2</em>, <em>EGFR</em>, <em>CCND1</em> i.e. cyclin D1, and <em>AKT1</em>) and their corresponding pathway signature genes.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>(A) Schematic overview of Q1-Q2 enrichment analysis. Enrichment is defined as a significant number of genes in the experimental set being located at or near the top of a population of genes rank-ordered by a given metric applied to the human tumor dataset. (B) Results of enrichment analysis in four different gene expression profile datasets of human prostate tumors <a href="#pone.0001816-Glinsky1">[5]</a>–<a href="#pone.0001816-Singh1">[8]</a>. Patterns of consensus among the various datasets (i.e. patterns observed in at least 2 or 3 datasets) are also represented. For each oncogene-to-pathway association, a red square indicates that genes in the pathway were enriched within the top genes most correlated with the oncogene. Anti-enrichment (blue square) indicates that genes in the pathway overlapped with the genes most anti-correlated with the oncogene. Associations between a given gene and its corresponding oncogenic pathway signature are highlighted with black outline.</p>
<span>doi:10.1371/journal.pone.0001816.g002</span></div><a id="article1.body1.sec2.sec2.p3" name="article1.body1.sec2.sec2.p3"></a><p>Results of the enrichment analysis are shown in <a href="#pone-0001816-g002">Figure 2B</a>. A major advantage in evaluating four independent prostate tumor datasets is that one may identify consistent patterns appearing in multiple datasets. Numerous patterns of enrichment were found in three of the four datasets examined (though none were found in all four). The major finding of the enrichment analysis was that genes up-regulated experimentally by Myc, c-Src, HER2 (erbB-2), Akt, or androgen were consistently co-expressed in human PCA with Myc, c-Src, HER2, Akt, or PSA, respectively. Associations of the cyclin D1 and EGFR pathway signatures with expression of <em>CCND1</em> and <em>EGFR</em>, respectively, were also observed in two of the four tumor datasets. Many of the gene sets from different oncogenic signature pathways shared significant overlap (<a href="#pone-0001816-g001">Figure 1I</a>), yet, interestingly, each pathway set associated uniquely with its corresponding oncogene; for example, the EGFR and erbB-2 signatures had many genes in common (<a href="#pone-0001816-g001">Figure 1B</a>), yet the EGFR signature genes did not associate with mRNA patterns of erbB-2 in the human data, and vice versa (<a href="#pone-0001816-g002">Figure 2B</a>). Another notable finding is that genes down-regulated in a given oncogenic signature did not show anticipated patterns of anti-enrichment.</p>
<a id="article1.body1.sec2.sec2.p4" name="article1.body1.sec2.sec2.p4"></a><p>The Q1Q2 enrichment analysis of <a href="#pone-0001816-g002">Figure 2B</a> was a ranked-based approach, where genes that were even weakly correlated with the reference gene of interest could partially contribute to a significant association (see ref <a href="#pone.0001816-Tian1">[16]</a> for details). Therefore, an alternative enrichment method, the classical one-sided Fisher's exact test, was also considered. For each of the androgen, Myc, Src, HER2, EGFR, cyclin D1, and Akt pathways, the top genes overlapping between the oncogenic signature and the correlates of the corresponding oncogene or biomarker in the human tumors were tabulated. The numerical results of the tabulation are given in <a href="#pone-0001816-t003">Table 3</a>, and the lists of genes overlapping between the experimental and human datasets for each pathway signature are given in Supplementary <a href="#pone.0001816.s003">Data File S3</a>. For <a href="#pone-0001816-t003">Table 3</a> and Supplementary <a href="#pone.0001816.s003">Data File S3</a>, positive correlation between a gene and the given oncogene within the human tumors was defined as showing statistical significance (<em>p</em>&lt;0.05, Pearson's correlation, two-sided) in at least three out of the four prostate profile datasets. Genes listed in Supplementary <a href="#pone.0001816.s003">Data File S3</a> were therefore both in the given pathway signature (as defined in <a href="#pone-0001816-t002">Table 2</a>) and individually correlated with the corresponding oncogene or biomarker in the human tumors.</p>
<div class="figure" id="pone-0001816-t003"><div class="img"><a name="pone-0001816-t003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001816" data-uri="info:doi/10.1371/journal.pone.0001816.t003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001816.t003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001816.t003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001816.t003.TIF"></span>)
                </a></li></ul></div><p><strong>Table 3.  <span>Number of genes overlapping between oncogenic signatures and human tumor correlates.</span></strong></p><span>doi:10.1371/journal.pone.0001816.t003</span></div><a id="article1.body1.sec2.sec2.p5" name="article1.body1.sec2.sec2.p5"></a><p>Except for the EGFR signature, there was non-random overlap between the set of genes in the experimentally-defined signature and the set of genes correlated in the human tumors with the reference oncogene or biomarker corresponding to the signature. For example, of the 559 genes in the Chen androgen signature (448 of which were represented in at least three prostate tumor datasets), 29 were correlated (<em>p</em>&lt;0.05) with <em>KLK3</em> in at least three out of the four prostate tumor datasets; by chance, nine were expected, and so the amount of actual overlap was quite significant (<em>p</em> = 1.2E-08). The overlap was not significant for the EGFR signature and was marginally significant (<em>p</em> = 0.02) for the cyclin D1 signature. The results of the Fisher's exact enrichment analysis (<a href="#pone-0001816-t003">Table 3</a>) appear consistent with the results of the Q1Q2 enrichment anlysis (<a href="#pone-0001816-g002">Figure 2B</a>), where the <em>EGFR</em> and <em>CCND1</em> analyses were significant in only two of the four datasets; relatively few genes (28) were individually correlated with <em>EGFR</em> mRNA in at least three human tumor datasets, and genes that were correlated in only two datasets would not have been included in the Fisher's exact analysis.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1"></a><p>In this study, several gene signatures of oncogenic pathways defined experimentally were found to be coordinately expressed with the single oncogene or biomarker corresponding to the pathway in human prostate tumors. These results demonstrate these signatures to be relevant to the study of human prostate cancer. These findings apply mainly for the sets of genes up-regulated in the signatures, as the down-regulated genes by and large did not show expected correlation patterns (<a href="#pone-0001816-g002">Figure 2B</a>). The gene-to-signature correlations of interest were observed in three of the four prostate tumor profiles datasets, but none were found in all four. The fact that no consistent patterns were found in all four datasets is curious but could be explained by a number of reasons, which could range from the technical (e.g. a “bad” gene probe or chip artifact in one dataset) to the biological (e.g. different patient cohorts being represented in different datasets). It should be emphasized that any association made between a gene and its corresponding signature for any one dataset was quite robust, the significance values testing against 1000 randomly-generated gene signature and 1000 permutations of the reference oncogene values (see <a href="#s4">Methods</a>). This study does underscore the value of the meta-analysis approach, as patterns that may be missed in one profile dataset could be repeatedly found in other datasets.</p>
<a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2"></a><p>In general, experimental data might be expected to show changes in gene expression that are merely artifacts of the model system, while human tumor data alone can show patterns of correlation but do not readily demonstrate cause-and-effect in the way experimental models can. For a given pathway, the intersection of the set of genes up-regulated by experimental activation of the pathway with the set of genes showing anticipated patterns of expression in human tumor tissue specimens would be a set of genes of potential interest to researchers. For the Myc, c-Src, HER2, EGFR, cyclin D1, Akt, and androgen pathways, this study provides the set of genes relevant to each pathway both experimentally and pathologically (<a href="#pone-0001816-t003">Table 3</a> and Supplementary <a href="#pone.0001816.s003">Data File S3</a>). Molecular biologists who study any one of these pathways may select candidate gene targets of these pathways uncovered by this study and validate the expression patterns both in experimental models (models using prostate cells in particular) and in human prostate tumor specimens.</p>
<a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3"></a><p>It is understood that a particular pathway may be deregulated through a number of different genes <a href="#pone.0001816-Hanahan1">[1]</a>, and so a measure of the “end point” of a signaling pathway at the transcription level may prove to be a better indicator of pathway deregulation over any single gene. The intersection of human and experimental profile data provides sets of genes that could possibly be used in a clinical diagnostic assay to infer which pathways are deregulated in patient tumors. RT-PCR assays using RNA from paraffin-embedded tissues have been developed <a href="#pone.0001816-Lehmann1">[17]</a>, and so it would be technically feasible to develop an RT-PCR-based, multi-gene assay for the status of various pathways in a given tumor, using genes selected from the results of this study.</p>
<a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4"></a><p>The analysis presented here implicates over-expression of Myc, Akt, c-Src, or erbB-2/HER2 with activation of their associated pathways in at least a subset of prostate tumors. The roles of Myc and Akt in prostate cancer initiation and progression have received much study <a href="#pone.0001816-AbateShen1">[18]</a>, <a href="#pone.0001816-Hughes1">[19]</a>, <a href="#pone.0001816-Majumder1">[14]</a>. The c-Src oncogene has apparently not received much attention in prostate cancer and is better known in other cancers such as colon <a href="#pone.0001816-Dehm1">[20]</a>. However, a truncated version of the c-Kit prostate was recently found in primary prostate tumors, which was correlated with activation of the Src pathway <a href="#pone.0001816-Paronetto1">[21]</a>. The role of erbB-2 is prostate cancer has been controversial, and there have been conflicting results over whether the gene is amplified or over-expressed <a href="#pone.0001816-Hughes1">[19]</a>. This present study indicates that there is a sub-population of prostate cancer patients that express erbB-2 and have its pathway activated; such patients could possibly benefit from current anti-erbB2 therapies, such as Herceptin, currently in use in breast cancer.</p>
<a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5"></a><p>Other recent molecular profiling studies (in addition to those referenced above) have demonstrated that gene expression patterns derived from experimental models are also observable in human tumors. For instance, transgenic mice over-expressing <em>Myc</em> shared many of the expression patterns observed in human prostate tumors having high <em>MYC</em> expression <a href="#pone.0001816-EllwoodYen1">[22]</a>; a mouse model of Kras2-mediated lung cancer shared expression patterns with human lung tumors harboring k-ras mutation <a href="#pone.0001816-SweetCordero1">[23]</a>; and an SV40 T/t-antigen cancer gene signature activated in transgenic mouse tumors with aberrant p53, Rb, or BRCA1 expression was associated with poor prognosis in human breast, prostate, and lung carcinomas <a href="#pone.0001816-Deeb1">[24]</a>. In this context, the present study represents a validation of the idea that gene expression patterns derived experimentally can be relevant to the study of human cancer at the transcriptomic level.</p>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Gene expression profile datasets</h4>
<a id="article1.body1.sec4.sec1.p1" name="article1.body1.sec4.sec1.p1"></a><p>The gene expression profile datasets described here were publicly available <a href="#pone.0001816-Lamb1">[2]</a>–<a href="#pone.0001816-Singh1">[8]</a>, <a href="#pone.0001816-Whitfield1">[10]</a>–<a href="#pone.0001816-Majumder1">[14]</a> (<a href="#pone-0001816-t001">Table 1</a>). Gene expression values were log-transformed. For the Chen androgen dataset <a href="#pone.0001816-Chen1">[12]</a>, expression values within the AR+ group of samples were transformed to standard deviations from the mean; values within the vector group of samples were separately transformed. Treatment of the Coller <em>et al</em>. dataset <a href="#pone.0001816-Coller1">[13]</a> is described in ref <a href="#pone.0001816-Creighton2">[15]</a>. Human prostate tumor datasets were transformed to standard deviations from the median. For the Lapointe <em>et al</em>. cDNA microarray dataset <a href="#pone.0001816-Lapointe1">[7]</a>, gene probes with missing values in at least half of the tumor specimens were removed from consideration. From the 66 PCA profiles described in the study by Yu <em>et al</em>. <a href="#pone.0001816-Yu1">[6]</a>, 60 were available for this study (collection for this dataset was facilitated by A.M. Chinnaiyan and the Oncomine team); the “adjacent tissue” (AT) profiles from the Yu study were not considered here. Expression values were visualized as heat maps using the Cluster <a href="#pone.0001816-Eisen1">[25]</a> and Java TreeView software <a href="#pone.0001816-Saldanha1">[26]</a>.</p>


<h4>Definition of oncogenic pathway signatures</h4>
<a id="article1.body1.sec4.sec2.p1" name="article1.body1.sec4.sec2.p1"></a><p>Two-sample <em>t</em>-tests determined significant differences in gene expression between groups of samples. Criteria for selection of genes in each oncogenic pathway signature was as follows: (1) Myc signature from Bild dataset, <em>p</em>&lt;0.001, comparing the Myc group with GFP control; Bild Ras signature, <em>p</em>&lt;0.00001; Bild E2F3 signature, <em>p</em>&lt;0.001; Bild beta-catenin signature, <em>p</em>&lt;0.001; Bild Src signature, <em>p</em>&lt;0.0001; erbB-2 (HER2) signature from Creighton dataset, <em>p</em>&lt;0.01, comparing HER2 group with MCF7/lt-E2 control; Creighton EGFR signature, <em>p</em>&lt;0.01; Creighton MEK signature, <em>p</em>&lt;0.01; Creighton Raf signature, <em>p</em>&lt;0.01; Creighton MAPK signature, described in ref <a href="#pone.0001816-Creighton1">[4]</a>; Whitfield cell cycle signature, described in ref <a href="#pone.0001816-Whitfield1">[10]</a>; androgen receptor (AR) signaling from Deprimo dataset, <em>p</em>&lt;0.01, comparing R1881-treated LNCaP samples with EtOH controls, and a minimum average red/green ratio of 1.8 in R1881 samples; AR signaling from Chen dataset, <em>p</em>&lt;0.001 for Pearson's correlation with log of R1881 concentration; Coller Myc signature, described in ref <a href="#pone.0001816-Creighton2">[15]</a>; Lamb cyclin D1 signature, <em>p</em>&lt;0.01 for Pearson's correlation with <em>CCND1</em> mRNA expression across all samples; Majumder Akt signature, <em>p</em>&lt;0.001, comparing AKT-Tg mouse prostate with wild-type (placebo-treated groups). False Discovery Rate (FDR) was computed for each oncogenic signature, using the method of <a href="#pone.0001816-Storey1">[27]</a>; the number of probes on the array was multiplied by the nominal <em>p</em>-value and divided by the number of probes in the oncogenic signature (FDR values listed in <a href="#pone-0001816-t002">Table 2</a>).</p>


<h4>Enrichment analyses</h4>
<a id="article1.body1.sec4.sec3.p1" name="article1.body1.sec4.sec3.p1"></a><p>In order to determine whether a specified group of experimentally-derived genes (e.g. genes induced in the Myc signature) had a coordinated association with a molecular phenotype of interest in human tumors (e.g. prostate tumors with high <em>MYC</em> expression relative to the other tumors), Q1-Q2 analysis was carried out essentially as described in <a href="#pone.0001816-Tian1">[16]</a>. Briefly, the common population of genes represented in the given human tumor profile dataset were ranked based on Pearson's correlation with the oncogene of interest (using only the primary PCA profiles and not profiles from metastatic or benign tissues). For genes in the experimental set of interest, the <em>t</em>-scores for the correlation coefficients in the ranked list were summed up; the significance of this sum was determined both by 1000 randomly selected gene sets (the Q1 hypothesis) and 1000 random permutations of the values for the reference gene (i.e. the oncogene used to rank the other genes) in the tumor dataset (the Q2 hypothesis). The sum of t-scores from the actual datasets were expressed as standard deviations from the mean of either the Q1 permutation results or the Q2 permutation results, with two-sided significance <em>p</em>-values determined assuming normal distributions of the permutation results. The higher of the Q1 and Q2 <em>p</em>-values determined enrichment (with both Q1 and Q2 required to move in the same direction).</p>
<a id="article1.body1.sec4.sec3.p2" name="article1.body1.sec4.sec3.p2"></a><p>The Entrez Gene identifier was used in mapping genes across the array datasets. For the prostate tumor datasets, where a gene was represented multiple times on a given platform, the “best” probe for the gene was selected in a manner not biased towards the direction of relative expression changes (the probe with the largest average signal intensity for the prostate tumor Affymetrix datasets, the probe with the least missing values across samples for the prostate cDNA microarray dataset). For the oncogenic signature gene sets, where a gene was represented by multiple array probes, the gene was represented at most once in a given set (it was possible within a signature for a given gene to be represented in both the “up” lists and the “down” lists by different probes, though this was the case for only a handful of genes). Where the probe selected to represent the reference oncogene or biomarker for ranking the entire gene population failed to show a significant association with the corresponding oncogenic signature, alternative probes representing the oncogene were tried.</p>

</div>

<div id="section5" class="section"><a id="s5" name="s5" toc="s5" title="Supporting Information"></a><h3>Supporting Information</h3><div class="figshare_widget" doi="10.1371/journal.pone.0001816"></div><a name="pone.0001816.s001" id="pone.0001816.s001"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001816.s001">Supplementary Data File S1. </a></strong></p><a id="article1.body1.sec5.supplementary-material1.caption1.p1" name="article1.body1.sec5.supplementary-material1.caption1.p1"></a><p class="preSiDOI">Lists of unique named genes in each of the oncogenic pathway signatures of <a href="#pone-0001816-t002">Table 2</a></p>
<p class="siDoi">doi:10.1371/journal.pone.0001816.s001</p><a id="article1.body1.sec5.supplementary-material1.caption1.p2" name="article1.body1.sec5.supplementary-material1.caption1.p2"></a><p class="postSiDOI">(2.53 MB XLS)</p>
<a name="pone.0001816.s002" id="pone.0001816.s002"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001816.s002">Supplementary Data File S2. </a></strong></p><a id="article1.body1.sec5.supplementary-material2.caption1.p1" name="article1.body1.sec5.supplementary-material2.caption1.p1"></a><p class="preSiDOI">Lists of the corresponding genes overlapping among the various oncogenic signatures.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001816.s002</p><a id="article1.body1.sec5.supplementary-material2.caption1.p2" name="article1.body1.sec5.supplementary-material2.caption1.p2"></a><p class="postSiDOI">(3.42 MB XLS)</p>
<a name="pone.0001816.s003" id="pone.0001816.s003"></a><p class="siTitle"><strong><a href="/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0001816.s003">Supplementary Data File S3. </a></strong></p><a id="article1.body1.sec5.supplementary-material3.caption1.p1" name="article1.body1.sec5.supplementary-material3.caption1.p1"></a><p class="preSiDOI">For each of the androgen, Myc, Src, HER2, EGFR, cyclin D1, and Akt pathways, lists of genes overlapping between the oncogenic signature and correlates of the corresponding oncogene or biomarker in human prostate tumors.</p>
<p class="siDoi">doi:10.1371/journal.pone.0001816.s003</p><a id="article1.body1.sec5.supplementary-material3.caption1.p2" name="article1.body1.sec5.supplementary-material3.caption1.p2"></a><p class="postSiDOI">(1.41 MB XLS)</p>
</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>The author would like to thank Fang Liu for technical assistance and all the contributors of the gene expression profile datasets used in this study.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: CC. Performed the experiments: CC. Analyzed the data: CC. Contributed reagents/materials/analysis tools: CC. Wrote the paper: CC.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001816-Hanahan1" id="pone.0001816-Hanahan1"></a>Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell  100: 57–70.  <ul class="find" data-citedArticleID="1076254" data-doi="10.1016/s0092-8674(00)81683-9"><li><a href="http://dx.doi.org/10.1016/s0092-8674(00)81683-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+hallmarks+of+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+hallmarks+of+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001816-Lamb1" id="pone.0001816-Lamb1"></a>Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, et al.  (2003) A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer. Cell  114: 323–334.  <ul class="find" data-citedArticleID="1076258" data-doi="10.1016/s0092-8674(03)00570-1"><li><a href="http://dx.doi.org/10.1016/s0092-8674(03)00570-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+Mechanism+of+Cyclin+D1+Action+Encoded+in+the+Patterns+of+Gene+Expression+in+Human+Cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+Mechanism+of+Cyclin+D1+Action+Encoded+in+the+Patterns+of+Gene+Expression+in+Human+Cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001816-Bild1" id="pone.0001816-Bild1"></a>Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al.  (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature  439: 353–7.  <ul class="find" data-citedArticleID="1076232" data-doi="10.1038/nature04296"><li><a href="http://dx.doi.org/10.1038/nature04296" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Oncogenic+pathway+signatures+in+human+cancers+as+a+guide+to+targeted+therapies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Oncogenic+pathway+signatures+in+human+cancers+as+a+guide+to+targeted+therapies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001816-Creighton1" id="pone.0001816-Creighton1"></a>Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, et al.  (2006) Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Cancer Res  66: 3903–11.  <ul class="find" data-citedArticleID="1076238" data-doi="10.1158/0008-5472.can-05-4363"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-05-4363" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Activation+of+mitogen-activated+protein+kinase+in+estrogen+receptor+alpha-positive+breast+cancer+cells+in+vitro+induces+an+in+vivo+molecular+phenotype+of+estrogen+receptor+alpha-negative+human+breast+tumors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Activation+of+mitogen-activated+protein+kinase+in+estrogen+receptor+alpha-positive+breast+cancer+cells+in+vitro+induces+an+in+vivo+molecular+phenotype+of+estrogen+receptor+alpha-negative+human+breast+tumors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001816-Glinsky1" id="pone.0001816-Glinsky1"></a>Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL (2004) Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest  113: 913–23.  <ul class="find" data-citedArticleID="1076252" data-doi="10.1172/jci20032"><li><a href="http://dx.doi.org/10.1172/jci20032" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+expression+profiling+predicts+clinical+outcome+of+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+expression+profiling+predicts+clinical+outcome+of+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001816-Yu1" id="pone.0001816-Yu1"></a>Yu YP, Landsittel D, Jing L, Nelson J, Ren B, et al.  (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol  22: 2790–9.  <ul class="find" data-citedArticleID="1076282" data-doi="10.1200/jco.2004.05.158"><li><a href="http://dx.doi.org/10.1200/jco.2004.05.158" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+expression+alterations+in+prostate+cancer+predicting+tumor+aggression+and+preceding+development+of+malignancy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+expression+alterations+in+prostate+cancer+predicting+tumor+aggression+and+preceding+development+of+malignancy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001816-Lapointe1" id="pone.0001816-Lapointe1"></a>Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, et al.  (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A  101: 811–6.  <ul class="find" data-citedArticleID="1076260" data-doi="10.1073/pnas.0304146101"><li><a href="http://dx.doi.org/10.1073/pnas.0304146101" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+expression+profiling+identifies+clinically+relevant+subtypes+of+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+expression+profiling+identifies+clinically+relevant+subtypes+of+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001816-Singh1" id="pone.0001816-Singh1"></a>Singh D, Febbo PG, Ross K, Jackson DG, Manola J, et al.  (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell  1: 203–9.  <ul class="find" data-citedArticleID="1076272" data-doi="10.1016/s1535-6108(02)00030-2"><li><a href="http://dx.doi.org/10.1016/s1535-6108(02)00030-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+expression+correlates+of+clinical+prostate+cancer+behavior." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+expression+correlates+of+clinical+prostate+cancer+behavior.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001816-Rhodes1" id="pone.0001816-Rhodes1"></a>Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM (2002) Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res  62: 4427–4433.  <ul class="find" data-citedArticleID="1076268"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Meta-analysis+of+microarrays%3A+interstudy+validation+of+gene+expression+profiles+reveals+pathway+dysregulation+in+prostate+cancer.&amp;auth=&amp;atitle=Meta-analysis+of+microarrays%3A+interstudy+validation+of+gene+expression+profiles+reveals+pathway+dysregulation+in+prostate+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Meta-analysis+of+microarrays%3A+interstudy+validation+of+gene+expression+profiles+reveals+pathway+dysregulation+in+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Meta-analysis+of+microarrays%3A+interstudy+validation+of+gene+expression+profiles+reveals+pathway+dysregulation+in+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001816-Whitfield1" id="pone.0001816-Whitfield1"></a>Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, et al.  (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell  13: 1977–2000.  <ul class="find" data-citedArticleID="1076280" data-doi="10.1091/mbc.02-02-0030."><li><a href="http://dx.doi.org/10.1091/mbc.02-02-0030." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+genes+periodically+expressed+in+the+human+cell+cycle+and+their+expression+in+tumors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+genes+periodically+expressed+in+the+human+cell+cycle+and+their+expression+in+tumors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001816-DePrimo1" id="pone.0001816-DePrimo1"></a>DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, et al.  (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol  3: R32.  <ul class="find" data-citedArticleID="1076242"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Transcriptional+programs+activated+by+exposure+of+human+prostate+cancer+cells+to+androgen.&amp;auth=&amp;atitle=Transcriptional+programs+activated+by+exposure+of+human+prostate+cancer+cells+to+androgen." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transcriptional+programs+activated+by+exposure+of+human+prostate+cancer+cells+to+androgen." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transcriptional+programs+activated+by+exposure+of+human+prostate+cancer+cells+to+androgen.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001816-Chen1" id="pone.0001816-Chen1"></a>Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, et al.  (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med  10: 33–9.  <ul class="find" data-citedArticleID="1076234" data-doi="10.1038/nm972"><li><a href="http://dx.doi.org/10.1038/nm972" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+determinants+of+resistance+to+antiandrogen+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+determinants+of+resistance+to+antiandrogen+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001816-Coller1" id="pone.0001816-Coller1"></a>Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, et al.  (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A  97: 3260–5.  <ul class="find" data-citedArticleID="1076236" data-doi="10.1073/pnas.97.7.3260"><li><a href="http://dx.doi.org/10.1073/pnas.97.7.3260" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+analysis+with+oligonucleotide+microarrays+reveals+that+MYC+regulates+genes+involved+in+growth%2C+cell+cycle%2C+signaling%2C+and+adhesion." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+analysis+with+oligonucleotide+microarrays+reveals+that+MYC+regulates+genes+involved+in+growth%2C+cell+cycle%2C+signaling%2C+and+adhesion.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001816-Majumder1" id="pone.0001816-Majumder1"></a>Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, et al.  (2004) mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med  10: 594–601.  <ul class="find" data-citedArticleID="1076264" data-doi="10.1038/nm1052"><li><a href="http://dx.doi.org/10.1038/nm1052" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=mTOR+inhibition+reverses+Akt-dependent+prostate+intraepithelial+neoplasia+through+regulation+of+apoptotic+and+HIF-1-dependent+pathways." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22mTOR+inhibition+reverses+Akt-dependent+prostate+intraepithelial+neoplasia+through+regulation+of+apoptotic+and+HIF-1-dependent+pathways.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001816-Creighton2" id="pone.0001816-Creighton2"></a>Creighton CJ, Cordero KE, Larios JM, Miller RS, Johnson MD, et al.  (2006) Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors. Genome Biol  7: R28.  <ul class="find" data-citedArticleID="1076240"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Genes+regulated+by+estrogen+in+breast+tumor+cells+in+vitro+are+similarly+regulated+in+vivo+in+tumor+xenografts+and+human+breast+tumors.&amp;auth=&amp;atitle=Genes+regulated+by+estrogen+in+breast+tumor+cells+in+vitro+are+similarly+regulated+in+vivo+in+tumor+xenografts+and+human+breast+tumors." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Genes+regulated+by+estrogen+in+breast+tumor+cells+in+vitro+are+similarly+regulated+in+vivo+in+tumor+xenografts+and+human+breast+tumors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Genes+regulated+by+estrogen+in+breast+tumor+cells+in+vitro+are+similarly+regulated+in+vivo+in+tumor+xenografts+and+human+breast+tumors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0001816-Tian1" id="pone.0001816-Tian1"></a>Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, et al.  (2005) Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A  102: 13544–9.  <ul class="find" data-citedArticleID="1076278" data-doi="10.1073/pnas.0506577102"><li><a href="http://dx.doi.org/10.1073/pnas.0506577102" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Discovering+statistically+significant+pathways+in+expression+profiling+studies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Discovering+statistically+significant+pathways+in+expression+profiling+studies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0001816-Lehmann1" id="pone.0001816-Lehmann1"></a>Lehmann U, Kreipe H (2001) Real-Time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods  25: 409–418.  <ul class="find" data-citedArticleID="1076262" data-doi="10.1006/meth.2001.1263"><li><a href="http://dx.doi.org/10.1006/meth.2001.1263" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Real-Time+PCR+analysis+of+DNA+and+RNA+extracted+from+formalin-fixed+and+paraffin-embedded+biopsies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Real-Time+PCR+analysis+of+DNA+and+RNA+extracted+from+formalin-fixed+and+paraffin-embedded+biopsies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0001816-AbateShen1" id="pone.0001816-AbateShen1"></a>Abate-Shen C, Shen MM (2000) Molecular genetics of prostate cancer. Genes Dev  14: 2410–34.  <ul class="find" data-citedArticleID="1076230" data-doi="10.1101/gad.819500"><li><a href="http://dx.doi.org/10.1101/gad.819500" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+genetics+of+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+genetics+of+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0001816-Hughes1" id="pone.0001816-Hughes1"></a>Hughes C, Murphy A, Martin C, Sheils O, O'Leary J (2005) Molecular pathology of prostate cancer. J Clin Pathol  58: 673–84.  <ul class="find" data-citedArticleID="1076256"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Molecular+pathology+of+prostate+cancer.&amp;auth=&amp;atitle=Molecular+pathology+of+prostate+cancer." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Molecular+pathology+of+prostate+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Molecular+pathology+of+prostate+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0001816-Dehm1" id="pone.0001816-Dehm1"></a>Dehm SM, Bonham K (2004) SRC gene expression in human cancer: the role of transcriptional activation. Biochem Cell Biol  82: 263–74.  <ul class="find" data-citedArticleID="1076246" data-doi="10.1139/o03-077"><li><a href="http://dx.doi.org/10.1139/o03-077" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=SRC+gene+expression+in+human+cancer%3A+the+role+of+transcriptional+activation." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22SRC+gene+expression+in+human+cancer%3A+the+role+of+transcriptional+activation.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0001816-Paronetto1" id="pone.0001816-Paronetto1"></a>Paronetto MP, Farini D, Sammarco I, Maturo G, Vespasiani G, et al.  (2004) Expression of a truncated form of the c-Kit tyrosine kinase receptor and activation of Src kinase in human prostatic cancer. Am J Pathol  164: 1243–51.  <ul class="find" data-citedArticleID="1076266" data-doi="10.1016/s0002-9440(10)63212-9"><li><a href="http://dx.doi.org/10.1016/s0002-9440(10)63212-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Expression+of+a+truncated+form+of+the+c-Kit+tyrosine+kinase+receptor+and+activation+of+Src+kinase+in+human+prostatic+cancer." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Expression+of+a+truncated+form+of+the+c-Kit+tyrosine+kinase+receptor+and+activation+of+Src+kinase+in+human+prostatic+cancer.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0001816-EllwoodYen1" id="pone.0001816-EllwoodYen1"></a>Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, et al.  (2003) Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell  4: 223–38.  <ul class="find" data-citedArticleID="1076250" data-doi="10.1016/s1535-6108(03)00197-1"><li><a href="http://dx.doi.org/10.1016/s1535-6108(03)00197-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Myc-driven+murine+prostate+cancer+shares+molecular+features+with+human+prostate+tumors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Myc-driven+murine+prostate+cancer+shares+molecular+features+with+human+prostate+tumors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0001816-SweetCordero1" id="pone.0001816-SweetCordero1"></a>Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, et al.  (2005) An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet  37: 48–55.  <ul class="find" data-citedArticleID="1076276" data-doi="10.1038/ng1490"><li><a href="http://dx.doi.org/10.1038/ng1490" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=An+oncogenic+KRAS2+expression+signature+identified+by+cross-species+gene-expression+analysis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22An+oncogenic+KRAS2+expression+signature+identified+by+cross-species+gene-expression+analysis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0001816-Deeb1" id="pone.0001816-Deeb1"></a>Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, et al.  (2007) Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res  2007 Sep 1;67(17): 8065–80.  <ul class="find" data-citedArticleID="1076244" data-doi="10.1158/0008-5472.can-07-1515"><li><a href="http://dx.doi.org/10.1158/0008-5472.can-07-1515" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Identification+of+an+integrated+SV40+T%2Ft-antigen+cancer+signature+in+aggressive+human+breast%2C+prostate%2C+and+lung+carcinomas+with+poor+prognosis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Identification+of+an+integrated+SV40+T%2Ft-antigen+cancer+signature+in+aggressive+human+breast%2C+prostate%2C+and+lung+carcinomas+with+poor+prognosis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0001816-Eisen1" id="pone.0001816-Eisen1"></a>Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A  95: 14863–8.  <ul class="find" data-citedArticleID="1076248" data-doi="10.1073/pnas.95.25.14863"><li><a href="http://dx.doi.org/10.1073/pnas.95.25.14863" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cluster+analysis+and+display+of+genome-wide+expression+patterns." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cluster+analysis+and+display+of+genome-wide+expression+patterns.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0001816-Saldanha1" id="pone.0001816-Saldanha1"></a>Saldanha AJ (2004) Java Treeview–extensible visualization of microarray data. Bioinformatics  20: 3246–8.  <ul class="find" data-citedArticleID="1076270" data-doi="10.1093/bioinformatics/bth349"><li><a href="http://dx.doi.org/10.1093/bioinformatics/bth349" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Java+Treeview%E2%80%93extensible+visualization+of+microarray+data." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Java+Treeview%E2%80%93extensible+visualization+of+microarray+data.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0001816-Storey1" id="pone.0001816-Storey1"></a>Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A  100: 9440–9445.  <ul class="find" data-citedArticleID="1076274" data-doi="10.1073/pnas.1530509100"><li><a href="http://dx.doi.org/10.1073/pnas.1530509100" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Statistical+significance+for+genomewide+studies." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Statistical+significance+for+genomewide+studies.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.XML" value="86237"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.PDF" value="433899"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g001.PNG_L" value="2125425"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g001.PNG_M" value="308873"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g001.PNG_S" value="16492"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g001.TIF" value="2915132"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g001.PNG_I" value="100917"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t001.PNG_L" value="184779"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t001.PNG_M" value="100385"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t001.PNG_S" value="11843"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t001.TIF" value="856292"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t001.PNG_I" value="30807"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t002.PNG_L" value="191749"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t002.PNG_M" value="106500"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t002.PNG_S" value="12868"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t002.TIF" value="881470"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t002.PNG_I" value="32700"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g002.PNG_L" value="1532791"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g002.PNG_M" value="218379"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g002.PNG_S" value="17237"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g002.TIF" value="2365874"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.g002.PNG_I" value="88543"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t003.PNG_L" value="145166"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t003.PNG_M" value="84422"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t003.PNG_S" value="10447"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t003.TIF" value="646256"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.t003.PNG_I" value="26550"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.s001.XLS" value="2533888"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.s002.XLS" value="3421184"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001816.s003.XLS" value="1409024"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001816&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001816" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001816&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001816&volume=&issue=&title=Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors&author_name=Chad%20J.%20Creighton&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001816" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816&amp;t=Multiple%20Oncogenic%20Pathway%20Signatures%20Show%20Coordinate%20Expression%20Patterns%20in%20Human%20Prostate%20Tumors" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816&title=Multiple%20Oncogenic%20Pathway%20Signatures%20Show%20Coordinate%20Expression%20Patterns%20in%20Human%20Prostate%20Tumors&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816&amp;title=Multiple%20Oncogenic%20Pathway%20Signatures%20Show%20Coordinate%20Expression%20Patterns%20in%20Human%20Prostate%20Tumors" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001816&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001816';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Multiple%20Oncogenic%20Pathway%20Signatures%20Show%20Coordinate%20Expression%20Patterns%20in%20Human%20Prostate%20Tumors http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001816" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001816" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">










          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Androgens%22" title="Search for articles in the subject area:'Androgens'"><div class="flagText">Androgens</div></a>
              <div data-categoryid="20571" data-articleid="26456"
                   data-categoryname="Androgens"
                   class="flagImage" title="Flag 'Androgens' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Carcinogenesis%22" title="Search for articles in the subject area:'Carcinogenesis'"><div class="flagText">Carcinogenesis</div></a>
              <div data-categoryid="20019" data-articleid="26456"
                   data-categoryname="Carcinogenesis"
                   class="flagImage" title="Flag 'Carcinogenesis' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cyclins%22" title="Search for articles in the subject area:'Cyclins'"><div class="flagText">Cyclins</div></a>
              <div data-categoryid="22357" data-articleid="26456"
                   data-categoryname="Cyclins"
                   class="flagImage" title="Flag 'Cyclins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Gene+expression%22" title="Search for articles in the subject area:'Gene expression'"><div class="flagText">Gene expression</div></a>
              <div data-categoryid="17515" data-articleid="26456"
                   data-categoryname="Gene expression"
                   class="flagImage" title="Flag 'Gene expression' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22MAPK+signaling+cascades%22" title="Search for articles in the subject area:'MAPK signaling cascades'"><div class="flagText">MAPK signaling cascades</div></a>
              <div data-categoryid="21105" data-articleid="26456"
                   data-categoryname="MAPK signaling cascades"
                   class="flagImage" title="Flag 'MAPK signaling cascades' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Oncogenes%22" title="Search for articles in the subject area:'Oncogenes'"><div class="flagText">Oncogenes</div></a>
              <div data-categoryid="20793" data-articleid="26456"
                   data-categoryname="Oncogenes"
                   class="flagImage" title="Flag 'Oncogenes' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Prostate+cancer%22" title="Search for articles in the subject area:'Prostate cancer'"><div class="flagText">Prostate cancer</div></a>
              <div data-categoryid="19371" data-articleid="26456"
                   data-categoryname="Prostate cancer"
                   class="flagImage" title="Flag 'Prostate cancer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Prostate+gland%22" title="Search for articles in the subject area:'Prostate gland'"><div class="flagText">Prostate gland</div></a>
              <div data-categoryid="49021" data-articleid="26456"
                   data-categoryname="Prostate gland"
                   class="flagImage" title="Flag 'Prostate gland' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=3086'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=1373'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=9886&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>

<div class="block sidebar-comments">
    <div class="header">
        <h3>Comments</h3>
    </div>
      <p><a href="/annotation/listThread.action?root=7703">Referee comments: Referee 1 (Jan Mollenhauer)</a><br>Posted by PLoS_ONE_Group</p>
</div>

</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
